Home / News / Events / Events detail
On July 6, the 5th Viva Live Broadcast was officially launched. Dr. Han. Dai, CIO of Viva Biotech and Head of Viva BioInnovator, shared his insights on the “Industry's Cutting-Edge Technology and the Future of Innovative Drug Research and Development.” Dr. Han Dai analyzed the background and future trends of early-stage R&D of innovative drugs from a global perspective. He stated, "From the standpoint of industry competition, we always need to follow the market, pay attention to the target selection of large pharmaceutical companies and biological start-ups, comprehensively analyze their capabilities and R&D abilities, and balance our advantages to differentiate ourselves from the competition.
He expressed the help of strategy selection for early drug development using case studies. By combining multiple technology platforms with high technology barriers, Viva has built an advanced and integrated platform to support preclinical innovative drug development with its strengths in Structure-Based Drug Development (SBDD). Using these various platforms, Viva can meet our customers' full range of preclinical drug development needs.
Please watch the video record of the broadcast through Tencent Video or BiliBili.
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us